Aktie A2QPCA PRIVETERRA ACQUISITION CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Priveterra Acquisition Corp. Nasdaq

Aktien

A2QPCA

US74275N2018

PMGMU

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Priveterra Acquisition : SUPPLEMENTAL NOTICE OF REDEMPTION OF CERTAIN WARRANTS (CUSIP 00791X118) - Form 8-K
AEON Biopharma Completes Business Combination With Priveterra Acquisition; Shares Slump
AEON Biopharma Announces Closing of Business Combination with Priveterra Acquisition Corp. and Provides Pipeline Update
Priveterra Acquisition Completes Merger With AEON Biopharma
Priveterra Acquisition Corp. Announces Completion of Business Combination with AEON Biopharma, Inc.
Priveterra Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Priveterra Acquisition Corp.(NasdaqCM:PMGM) dropped from NASDAQ Composite Index
AEON Biopharma, Inc. completed the acquisition of Priveterra Acquisition Corp. from Priveterra Sponsor, LLC, Empyrean Capital Overseas Master Fund, Ltd., managed by Empyrean Capital Partners, LP, Medy-Tox Inc., Daewoong pharmaceutical Co.,Ltd, Strathspey Crown LLC and others in a reverse merger transaction.
Priveterra Acquisition Gets New York Stock Exchange Approval for Listing of AEON Biopharma Stock, Warrants
Priveterra Acquisition Corp. Announces Authorization to List on NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.
Priveterra Acquisition to Transfer Stock Listing to NYSE After Completing Business Combination
Priveterra Acquisition Corp. Announces Intention to Transfer to NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.
Top Premarket Decliners
AEON Biopharma and Priveterra Announce Arrangement of Up to $125 Million of Financing in Connection with Proposed Business Combination
Priveterra Acquisition : SPONSOR, LLC - Form 8-K
PRIVETERRA ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
PRIVETERRA ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)
PRIVETERRA ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
PRIVETERRA ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
PRIVETERRA ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QPK4 Aktie
  4. A2QPCA Aktie
  5. Nachrichten Priveterra Acquisition Corp.
  6. Andere Sprachen